Allergen-related approaches to immunotherapy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pharmacology and Therapeutics

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pharmthera.2008.11.007PMID 19111571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Three-Dimensional Structure of the Cross-Reactive Pollen Allergen Che a 3: Visualizing Cross-Reactivity on the Molecular Surfaces of Weed, Grass, and Tree Pollen Allergens1

  2008cited by this paper
• Advantages and disadvantages of accelerated immunotherapy schedules.

  2008cited by this paper
• Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-β-dependent mechanism

  2008cited by this paper
• Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy.

  2008cited by this paper
• Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years.

  2008cited by this paper
• Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.

  2008cited by this paper
• Role of pollen NAD(P)H oxidase in allergic inflammation

  2008cited by this paper
• ALLERGY Net: High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis

  2008cited by this paper
• The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

  2008cited by this paper
• Treatment with Mycobacterium vaccae ameliorates airway histopathology in a murine model of asthma.

  2008cited by this paper
• Basophil activation test by flow cytometry: Present and future applications in allergology

  2008cited by this paper
• Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy.

  2008cited by this paper
• Sublingual immunotherapy.

  2008cited by this paper
• Update on mechanisms of allergen injection immunotherapy

  2008cited by this paper
• Latex allergy: a model for therapy

  2008cited by this paper
• Toll‐like receptor 2 agonist Pam3CSK4 enhances the induction of antigen‐specific tolerance via the sublingual route

  2008cited by this paper
• Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.

  2007cited by this paper
• Proteases as Th2 adjuvants

  2007cited by this paper
• Regulatory T cells and infection: a dangerous necessity

  2007cited by this paper
• Grass Pollen Immunotherapy Induces an Allergen-Specific IgA2 Antibody Response Associated with Mucosal TGF-β Expression1

  2007cited by this paper
• The safety of allergen specific sublingual immunotherapy.

  2007cited by this paper
• Regulatory conversation between antigen presenting cells and regulatory T cells enhance immune suppression.

  2007cited by this paper
• Allergen injection immunotherapy for seasonal allergic rhinitis.

  2007cited by this paper
• Beekeepers anaphylaxis: successful immunotherapy covered by omalizumab

  2007cited by this paper
• Allergen immunotherapy: where is it now?

  2007cited by this paper
• Eat dirt: CpG DNA and immunomodulation of asthma.

  2007cited by this paper
• Recombinant allergens for immunotherapy.

  2007cited by this paper
• Mechanisms of allergen-specific immunotherapy.

  2007cited by this paper
• Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study.

  2007cited by this paper
• Expansion of circulating Foxp3+CD25bright CD4+ T cells during specific venom immunotherapy

  2007cited by this paper
• Role of superallergens in allergic disorders.

  2007cited by this paper
• Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.

  2007cited by this paper
• Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT study

  2007cited by this paper
• Design, engineering and in vitro evaluation of MHC class‐II targeting allergy vaccines

  2007cited by this paper
• CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells

  2007cited by this paper
• Mechanisms of allergen-specific immunotherapy.

  2007cited by this paper
• The protease allergen Der p 1 cleaves cell surface DC‐SIGN and DC‐SIGNR: experimental analysis of in silico substrate identification and implications in allergic responses

  2007cited by this paper
• Peptide immunotherapy for allergic diseases

  2007cited by this paper
• A Novel Approach to Specific Allergy Treatment: The Recombinant Allergen-S-Layer Fusion Protein rSbsC-Bet v 1 Matures Dendritic Cells That Prime Th0/Th1 and IL-10-Producing Regulatory T Cells1

  2007cited by this paper
• Allergen immunotherapy: a practice parameter second update.

  2007cited by this paper
• Immunotherapy With a Ragweed-Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis

  2007cited by this paper
• Immune regulation by CD4+CD25+ T cells and interleukin‐10 in birch pollen‐allergic patients and non‐allergic controls

  2007cited by this paper
• Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.

  2007cited by this paper
• Allergen immunotherapy: a practice parameter second update.

  2007cited by this paper
• Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease

  2006cited by this paper
• Regulatory T cells

  2006cited by this paper
• Allergic disease and sensitization in Steiner school children.

  2006cited by this paper
• Immune mechanisms of allergen‐specific sublingual immunotherapy

  2006cited by this paper
• Safety and Efficacy of Juniperus ashei Sublingual-Swallow Ultra-Rush Pollen Immunotherapy in Cypress Rhinoconjunctivitis

  2006cited by this paper
• Mechanisms of allergen specific immunotherapy – T‐cell tolerance and more

  2006cited by this paper
• Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.

  2006cited by this paper
• Sublingual immunotherapy: a comprehensive review.

  2006cited by this paper
• Safety of a SQ‐standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo‐controlled trial

  2006cited by this paper
• Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys.

  2006cited by this paper
• Drugs for asthma

  2006cited by this paper
• Efficacy of sublingual immunotherapy in asthma: systematic review of randomized‐clinical trials using the Cochrane Collaboration method

  2006cited by this paper
• Pollinex® Quattro: a novel and well–tolerated, ultra short–course allergy vaccine

  2006cited by this paper
• CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells.

  2006cited by this paper
• Anaphylaxis by latex sublingual immunotherapy

  2006cited by this paper
• Immunological mechanisms of allergen-specific immunotherapy

  2006cited by this paper
• Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets.

  2006cited by this paper
• Sublingual immunotherapy with Dermatophagoides monomeric allergoid down‐regulates allergen‐specific immunoglobulin E and increases both interferon‐γ‐ and interleukin‐10‐production

  2006cited by this paper
• Plasmacytoid DCs and Treg cells: casual acquaintance or monogamous relationship?

  2006cited by this paper
• Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.

  2006cited by this paper
• Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization

  2005cited by this paper
• The safety of sublingual‐swallow immunotherapy: an analysis of published studies

  2005cited by this paper
• Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells1

  2005cited by this paper
• Monophosphoryl lipid A (MPL®) * promotes allergen‐induced immune deviation in favour of Th1 responses

  2005cited by this paper
• Post‐marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

  2005cited by this paper
• Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial.

  2005cited by this paper
• Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis *

  2005cited by this paper
• New chemokine targets for asthma therapy

  2005cited by this paper
• Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL‐)two to tango

  2005cited by this paper
• Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.

  2005cited by this paper
• Human CD1-restricted T cell recognition of lipids from pollens

  2005cited by this paper
• Hypoallergenic Variants of the Major Latex Allergen Hev b 6.01 Retaining Human T Lymphocyte Reactivity1

  2004cited by this paper
• Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils

  2004cited by this paper
• Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.

  2004cited by this paper
• Allergen-responsive CD4+CD25+ Regulatory T Cells in Children who Have Outgrown Cow's Milk Allergy

  2004cited by this paper
• Cutting Edge: TGF-β Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells1

  2004cited by this paper
• Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.

  2004cited by this paper
• Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.

  2004cited by this paper
• Omalizumab-induced reductions in mast cell Fce psilon RI expression and function.

  2004cited by this paper
• Regulatory T Cell Suppression and Anergy Are Differentially Regulated by Proinflammatory Cytokines Produced by TLR-Activated Dendritic Cells1

  2004cited by this paper
• Allergy Vaccine Engineering: Epitope Modulation of Recombinant Bet v 1 Reduces IgE Binding but Retains Protein Folding Pattern for Induction of Protective Blocking-Antibody Responses1

  2004cited by this paper
• The global burden of asthma: executive summary of the GINA Dissemination Committee Report

  2004cited by this paper
• Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects

  2004cited by this paper
• Increased allergen concentration enhances IFN‐γ production by allergic donor T cells expressing a peripheral tissue trafficking phenotype

  2004cited by this paper
• Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.

  2004cited by this paper
• Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells

  2004cited by this paper
• Regulatory T cells and mechanisms of immune system control

  2004cited by this paper
• Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism.

  2004cited by this paper
• Induction of T ‘regulatory’ cells by standardized house dust mite immunotherapy: an increase in CD4+CD25+ interleukin‐10+ T cells expressing peripheral tissue trafficking markers

  2004cited by this paper
• High Dose Allergen Stimulation of T Cells from House Dust Mite-Allergic Subjects Induces Expansion of IFN-γ+ T Cells, Apoptosis of CD4+IL-4+ T Cells and T Cell Anergy

  2004cited by this paper
• Targeting Th2 cells in asthmatic airways.

  2004cited by this paper
• Regulatory T cells: friend or foe in immunity to infection?

  2004cited by this paper
• Usefulness of mycobacteria in redirecting the immune response in atopic disease

  2004cited by this paper
• Immunotherapeutic uses of CpG oligodeoxynucleotides

  2004cited by this paper
• Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.

  2004cited by this paper
• Omalizumab-induced reductions in mast cell FcεRI expression and function

  2004cited by this paper

• Impact of antigen loading in tolerogenic nanoparticles to mitigate Th2-mediated allergic lung inflammation

  2024cites this paper
• Allergen‐specific immunotherapy induces monocyte‐derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mouse model

  2022cites this paper
• Other Drugs for Asthma and COPD

  2021cites this paper
• Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen season.

  2020cites this paper
• New and old adjuvants in allergen‐specific immunotherapy: With a focus on nanoparticles

  2020cites this paper
• Mapping Mimotopes for House Dust Mite Allergen Der f 7 Using a Specific Monoclonal Antibody.

  2019cites this paper
• Thermal processing influences the digestibility and immunoreactivity of muscle proteins of Scylla paramamosain

  2018cites this paper
• Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases

  2018cites this paper
• Virus-like particles in der Prophylaxe und Immuntherapie allergischer Erkrankungen

  2018cites this paper
• Wheat gliadin deamidated by cation-exchange resins induces oral tolerance in a mouse model of wheat allergy

  2018cites this paper
• Cibles et immunothérapies innovantes dans le traitement de l’allergie alimentaire

  2017cites this paper
• Lactobacillus buchneri S‐layer as carrier for an Ara h 2‐derived peptide for peanut allergen‐specific immunotherapy

  2017cites this paper
• Biomarqueurs systémiques associés à l'asthme persistant ou sévère de l'enfant

  2017cites this paper
• Effect of thermal processing on T cell reactivity of shellfish allergens - Discordance with IgE reactivity

  2017cites this paper
• Development of novel therapeutic approaches: (I) Targeting allergic responses to peanuts and (II) Inhibition of DPP-IV enzyme involved in diabetes

  2017cites this paper
• Treatment with grass allergen peptides improves symptoms of grass pollen–induced allergic rhinoconjunctivitis

  2017cites this paper
• IDENTIFICATION OF MAJOR ALLERGENIC SPOTS OF CERITHIDEA OBTUSA ( OBTUSE HORN SHELL ) BY TWO-DIMENSIONAL ELECTROPHORESIS ( 2-DE ) AND IMMUNOBLOTTING

  2016cites this paper
• Current developments for improving efficacy of allergy vaccines

  2015cites this paper
• Fascinating Findings from Sensitizing the Wistar Strain Rats Recruited as Peanut-Allergy Model

  2015cites this paper
• Shellfish Allergy: a Comprehensive Review

  2015cites this paper
• Arthropod venom Hyaluronidases: biochemical properties and potential applications in medicine and biotechnology

  2015cites this paper
• Structure, Size, and Solubility of Antigen Arrays Determines Efficacy in Experimental Autoimmune Encephalomyelitis

  2014cites this paper
• Pea proteins immunotherapy in peanut allergic mice model

  2014cites this paper
• Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis

  2014cites this paper
• All-cause and CVD-specific mortality associated with allergic rhinitis and allergic asthma: a retrospective cohort study

  2014influential citation
• Tolerogenic Dendritic Cells Derived from Donors with Natural Rubber Latex Allergy Modulate Allergen-Specific T-Cell Responses and IgE Production

  2014cites this paper
• Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs

  2014cites this paper
• O paciente alérgico no consultório de Medicina Dentária

  2014cites this paper
• Use of Animal Models to Investigate Major Allergens Associated with Food Allergy

  2013cites this paper
• Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic

  2013cites this paper
• Immunotherapy of Allergic Rhinitis: New Therapeutic Opportunities with Virus-like Particles Filled with Cpg Motifs

  2013cites this paper
• Allergen-specific immunotherapy: update on immunological mechanisms.

  2013cites this paper
• Pollinex Quattro: An innovative four injections immunotherapy In allergic rhinitis

  2013cites this paper
• Analysis Of Ige Reactivity To Pru Du 6, An 11s Globulin From Almond Nut, And Identification Of Both Sequential And Conformational Epitopes

  2013influential citation
• In silico prediction of Ara h 2 T cell epitopes in peanut‐allergic children

  2013cites this paper
• 'PROBIOTIC BACTERIA ADMINISTRATION AS AN IMMUNO- MODULATORY APPROACH FOR FOOD ALLERGY TREATMENT: PRECLINICAL STUDIES IN MOUSE MODELS'

  2013cites this paper
• T-cell responses during allergen-specific immunotherapy

  2012cites this paper
• Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy

  2012cites this paper
• Comparison of allergenic components and biopotency in whole body extracts of wild and laboratory reared American cockroaches, Periplaneta americana.

  2012cites this paper
• Development of poly(anhydride) nanoparticles loaded with peanut proteins: the influence of preparation method on the immunogenic properties.

  2012cites this paper
• Oral immunotherapy with immunodominant T‐cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy

  2012cites this paper
• Nanotechnology in Vaccine Development

  2012cites this paper
• Effects of Ionized Waterfall Aerosol on Pediatric Allergic Asthma

  2012cites this paper
• Unique and Cross-Reactive T Cell Epitope Peptides of the Major Bahia Grass Pollen Allergen, Pas n 1

  2012cites this paper
• 3-years' long-term effect of subcutaneous immunotherapy (SCIT) with a high-dose hypoallergenic 6-grass pollen preparation in adults.

  2012influential citation
• Regulatory T cells in allergic asthma.

  2012cites this paper
• Subcutaneous Allergen-specific Immunotherapy Versus Topical Treatment in Vernal Keratoconjunctivitis

  2012cites this paper
• Adjuvant effects of different TLR agonists on the induction of allergen-specific Th2 responses

  2012influential citation
• Hypoallergenic high-dose immunotherapy proves effective and safe in a multicentre surveillance study

  2012cites this paper
• Recombinant Allergens and Applications

  2012cites this paper
• Allergenic Diversity among Plant and Animal Food Proteins

  2012cites this paper
• An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential

  2012cites this paper
• Penaeus monodon tropomyosin induces CD4 T-cell proliferation in shrimp-allergic patients.

  2012cites this paper
• Cur l 3, a major allergen of Curvularia lunata-derived short synthetic peptides, shows promise for successful immunotherapy.

  2011cites this paper
• Ara h 2: crystal structure and IgE binding distinguish two subpopulations of peanut allergic patients by epitope diversity

  2011cites this paper
• C4 Drugs for the treatment of airway disease

  2011cites this paper
• Transconjunctival immunotherapy using cholera toxin B to treat experimental allergic conjunctivitis in a mouse model

  2011cites this paper
• Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy.

  2011cites this paper
• Soluble Antigen Arrays utilize molecular and physical features to suppress Experimental Autoimmune Encephalomyelitis

  2011cites this paper
• Perioperative Latex Allergy

  2011cites this paper
• Preliminary Studies on the Prevention of the Ovalbumin-Induced Allergic Response by Enterococcus faecalis CECT7121 in Mice

  2011cites this paper
• by vaccination with CTLA-4 -antigen combination-encoding

  2011cites this paper
• Treatment of allergic asthma: Modulation of Th2 cells and their responses

  2011cites this paper
• Assessing Protein Immunogenicity with a Dendritic Cell Line-Derived Endolysosomal Degradome

  2011cites this paper
• Ara h 2 peptides containing dominant CD4+ T-cell epitopes: candidates for a peanut allergy therapeutic.

  2011cites this paper
• Allergen Specific Immunotherapy as an Effective Therapy for Seasonal and Perennial Allergic Rhinitis Patients

  2011cites this paper
• Induction of Immune Tolerance in Asthmatic Mice by Vaccination with DNA Encoding an Allergen–Cytotoxic T Lymphocyte-Associated Antigen 4 Combination

  2011influential citation
• Purification of the Major Group 1 Allergen from Bahia Grass Pollen, Pas n 1

  2010cites this paper
• Regulatory T Cells in Many Flavors Control Asthma

  2010cites this paper
• Hyposensitization in the treatment of resistant cases of vernal keratoconjunctivitis

  2010cites this paper
• T cell responses induced by allergen‐specific immunotherapy

  2010cites this paper
• Shellfish allergy

  2010cites this paper
• Mechanisms of corneal allergic reaction: new options for treatment

  2010cites this paper
• Harnessing regulatory T cells to suppress asthma: from potential to therapy.

  2010cites this paper
• This information is current as Mucosal Immunization Tolerance or Enhanced Priming Following ADP-Ribosylation Controls the Outcome of

  2010cites this paper
• ADP-Ribosylation Controls the Outcome of Tolerance or Enhanced Priming Following Mucosal Immunization

  2010cites this paper
• Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening.

  2010cites this paper
• Functional regulatory T cells and allergen immunotherapy

  2010cites this paper
• Diode laser treatment in therapy-resistant allergic rhinitis: impact on nasal obstruction and associated symptoms

  2010cites this paper
• The impact of molecular biology on allergen immunotherapy

  2010cites this paper
• Advances in allergen-specific immunotherapy.

  2009cites this paper
• Modification of the innate immune function of dendritic cells by allergen‐specific immunotherapy

  2009cites this paper
• House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells.

  2009cites this paper
• Bibliography. Current world literature.

  2009cites this paper
• House dust mite sublingual immunotherapy - the role for TGF-beta and functional regulatory T cells

  2009cites this paper
• Treating allergy: where to from here?

  2009cites this paper
• Medical (Nonsurgical) Intervention Alone Is Now Best for Prevention of Stroke Associated With Asymptomatic Severe Carotid Stenosis: Results of a Systematic Review and Analysis

  2009cites this paper
• Various TLR antagonists treatment effects on the development of allergen-specific re - sponses

  year unknowncites this paper